baber/WOPTO huggingface dataset:
Patent AU-764829-B2 (AU)
Title: Automatic invocation of mobile IP registration in a wireless communication network
Inventor: LIOY MARCELLO
IPC: H04L29/12
Filed: 2000-01-20
Granted: 2003-09-04
Abstract: A system and method for invoking the performance of mobile node registration in a wireless communication network. The system comprises a terminal device for transmitting and receiving packetized data and a communication device coupled to the terminal device. The communication device monitors the packetized data for an Internet Protocol (IP) address contained in an IP address request. If the IP address request is for a static IP address the communication device waits for network movement information. Based on the received network movement information, the communication device solicits network address information. Upon receipt of the network address information, the terminal device then initiates Mobile Node registration. As a result, the Mobile Node registration is automatically invoked whenever the terminal device changes its network point-of-attachment.
Patent AU-624346-B2 (AU)
Title: Magnetic tape cassette
Inventor: KURASHINA SATORU
IPC: G11B23/04
Filed: 1988-12-21
Granted: 1992-06-11
Abstract: A magnetic tape cassette has a slidable braking member (16) to control the rotation of reel hubs around which a magnetic tape is wound. In order to facilitate the process of assembling the magnetic tape cassette, the braking member (16) is temporarily secured to an upper part (2) of the cassette housing with a light pressure, by the engagement of engaging recesses (2) around pins (15), at a position outside its normal slidable range. After the completion of the assembly, the braking member (16) is disengaged from the upper part (2) of the cassette housing, and thereafter it moves only within its normal slidable range in order to lock or release the reel hubs.
Patent AU-620584-B2 (AU)
Title: The use of moclobemide to treat or prevent cognitive disorders
Inventor: AMREIN ROMAN
IPC: A61K31/5375
Filed: 1989-01-27
Granted: 1992-02-20
Abstract: The use of p-chloro-N-(2-morpholinoethyl)benzamide (I) for treating and preventing cognitive disorders to new.
Patent AU-701503-B2 (AU)
Title: Methods of synthesis of peptidyl argininals
Inventor: WEBB THOMAS R
IPC: C07D207/16
Filed: 1995-06-19
Granted: 1999-01-28
Abstract: This invention provides solution-phase and solid-phase methods for the synthesis of peptidyl argininals and to novel reagents useful therein, which have formula (I), wherein R1 is selected from the group consisting of hydrogen, benzyloxycarbonyl, isonicotinyloxycarbonyl, 2-chlorobenzyloxycarbonyl, 4-methoxybenzyloxycarbonyl, t-butoxycarbonyl, t-amyloxycarbonyl, isobornyloxycarbonyl, adamantyloxycarbonyl, 2-(4-biphenyl)-2-propyloxycarbonyl, 9-fluorenylmethoxycarbonyl and methylsulfonylethoxycarbonyl; R2 is selected from the group consisting of alkyl of 1 to about 12 carbon atoms and aralkyl of about 7 to about 15 carbon atoms, either of which is optionally substituted with hydroxy or -CO-Y, wherein Y is hydroxy, alkoxy of 1 to about 12 carbon atoms, aralkoxy of about 7 to about 15 carbon atoms, O-polymeric support or NH-polymeric support; R3 is selected from the group consisting of hydrogen, Fmoc, nitro, benzyloxycarbonyl, t-butoxycarbonyl and adamantyloxycarbonyl; and R4 is selected from the group consisting of hydrogen, alkyl of 1 to about 12 carbon atoms, aryl of about 6 to about 14 carbon atoms and aralkyl of about 7 to about 15 carbon atoms; and salts thereof.
Patent AU-658966-B2 (AU)
Title: Water-in-oil emulsions
Inventor: DAHMS GERD HERBERT
IPC: A61K8/25
Filed: 1993-01-28
Granted: 1995-05-04
Abstract: The invention concerns a process for producing a water-in-oil emulsion comprising mixing an oil dispersion of particles of a metallic oxide having a primary particle size less than 0.2 micron with one or more emulsifiers and an aqueous phase. The method enables the production of such emulsions containing relatively small quantities of emulsifiers and a novel emulsion made available by the invention contains less than 1% by weight of emulsifiers, 10 to 60% by weight of an oil phase and at least 40% by weight of an aqueous phase. The emulsions so formed are useful in preparing UV absorbing compositions such as sunscreens, skin protectants, moisturisers and after-sun lotions.
Patent AU-692293-B2 (AU)
Title: Anthracyclinone derivatives and their use in amyloidosis
Inventor: SUARATO ANTONINO
IPC: C07C66/00
Filed: 1995-07-24
Granted: 1998-06-04
Abstract: The present invention provides the new use in the treatment of amyloidosis with the anthracyclinone of formula (A) wherein R1, R2, R3, R4, and R5, are appropriate substituents. Some compounds of formula (A) are novel. Processes for their preparation and pharmaceutical composition containing them are also described.
Patent AU-608141-B2 (AU)
Title: Ortho-substituted phenol ethers and fungicides which contain these compounds
Inventor: SCHUETZ FRANZ
IPC: C07C69/736
Filed: 1989-03-30
Granted: 1991-03-21
Abstract: Ortho-substituted phenol ethers of the general formula I   <IMAGE> I where R1is C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkylthio or amino which is unsubstituted or mono- or disubstituted by C1-C4-alkyl, R2 is C1-C4-alkyl, R3 is aryloxy, arylthio or arylalkoxy, the aromatic ring being unsubstituted or substituted by one or more of the following radicals: halogen, C1-C6-alkyl, C1-C6-alkoxy, C1-C4-alkylthio, C1-C2-haloalkyl, aryl, aryl-C1-C2-alkoxy, C1-C4-alkylcarbonyl, mono- or di-C1-C4-alkylsubstituted amino, cyano, nitro, X is CH or N, and Y is saturated or unsaturated C2-C12-alkylene, and fungicides containing these compounds.
Patent AU-733714-B2 (AU)
Title: Enhanced stimulation of erythropoiesis
Inventor: BELL DAVID
IPC: A61K38/22
Filed: 1997-08-27
Granted: 2001-05-24
Abstract: The present invention is directed to compositions comprising heme-containing components and to methods that stimulate erythropoiesis comprising administration of a composition of the invention, such as purified hemoglobin. Surprisingly, heme-containing components such as hemoglobin can induce erythropoiesis in the presence of decreased concentrations of erythropoietin (Epo) and, in fact, functions synergistically with Epo. Further, heme-containing components can be used alone or in conjunction with Epo for the treatment of anemias and other disorders due to decreases in erythropoietin or iron. It has been discovered that, in the presence of Epo, both hemoglobin and cross-linked hemoglobin can compensate for the reduction in erythroid cell growth and differentiation that occurs in the presence of reduced concentrations of Epo. The effect is specific to erythropoiesis, as evidenced by a lack of growth of non-erythroid progenitors such as CFU-GM.
Patent AU-570546-B2 (AU)
Title: Thermoplastic resin composition containing cork
Inventor: GOULDING LESLIE BENJAMIN
IPC: C08L101/00
Filed: 1985-03-19
Granted: 1988-03-17
Abstract: A rail pad or other shaped article in the form of a resiliently compressible extrudate having a textured surface and bomprising particles or granules of cork or similar resiliently compressible cellular material substantially homogenously bispersed throughout a polymeric matrix of generally saturated thermoplastic synthetic resin, preferably ethylene/vinyl acetate copolymer, which has a stiffness modulus of not more than 1000 MPa and is extrudable under conditions at which the cellular material is not significantly degraded, the extrudate having a Poissons ratio less than that of the matrix. The article may be made by forming a hot dough of the matrix and cellular material, feeding the dough in heat-softened state to an extruder, extruding it under conditions which compress the celluar material but avoid any significant mechanical breakdown or denaturing thereof, and relieving the compression of the cellular material downstream of the die but before the matrix has cooled to a temperature which would prevent this.
Patent AU-667551-B2 (AU)
Title: A fuel dispensing system
Inventor: GROSE JOHN STEPHEN
IPC: G01M3/28
Filed: 1993-07-20
Granted: 1996-03-28
Abstract: A fuel dispensing system includes a fuel reservoir (22) and a pump (24) to pump fuel from the reservoir (22) into a first leg of piping (26). A master dispenser (30) downstream of the first leg of piping has an outlet hose (38), a user-controllable switch activatable to turn on the pump to pump fuel from the reservoir to the master dispenser and a satellite dispenser (70), via a meter (28) arranged to detect the flow of fuel being dispensed through the dispensers. Electronic leak detection means periodically activates the pump when it is in a non dispensing state and monitors the meter's output for detection of flow of motor fuel indicating a leak and outputs a leak detection signal when such flow is detected. In an alternative embodiment the master dispenser can be replaced with a remote metering station for the satellite dispenser. <IMAGE>
Patent AU-778728-B2 (AU)
Title: Sago fluidity starch and use thereof
Inventor: HANCHETT DOUGLAS J
IPC: A23L17/00
Filed: 2000-07-03
Granted: 2004-12-16
Abstract: The present invention is directed to sago fluidity starch and the use thereof. Such fluidity starches exhibit exceptionally fast gelling properties, high gel strengths, and exceptional elasticity. These properties allow for significantly reduced processing times, including reduced hold times. Further, the higher gel strength allows for reduced starch levels without loss of final product gel strength integrity or texture.
Patent AU-618444-B2 (AU)
Title: New process for separating optical isomers of 1,4-dihydropyridine derivatives
Inventor: PEGLION JEAN-LOUIS
IPC: C07B57/00
Filed: 1990-01-12
Granted: 1991-12-19
Abstract: New process for separating optical isomers of the compounds of general formula I: <IMAGE>  in which:   - Ar denotes a phenyl radical optionally containing one to five identical or different substituents, each denoting a halogen atom, an alkoxy radical containing from 1 to 4 carbon atoms, an alkylthio radical containing from 1 to 4 carbon atoms, a trihalomethyl radical or a methylenedioxy radical, - each of Y, Z, Y1 and Z1, which are identical or different, denotes a hydrogen atom, a linear or branched lower alkyl radical containing from 1 to 4 carbon atoms, a cyclopropyl radical, a dicyclopropylmethyl radical, a 2,2-dicyclopropylethyl radical, a 2,2-dicyclopropylethylene radical, a 3,3-dicyclopropylpropyl radical, a 3,3-dicyclopropyl-1-propylene radical, a linear or branched alkylene radical containing from 2 to 5 carbon atoms or a phenyl radical optionally substituted by a nitro radical, and   - n is equal to 1, 2 or 3.
Patent AU-722978-B2 (AU)
Title: Magnetically activated cell sorting for production of proteins
Inventor: SIEGEL DONALD L
IPC: G01N33/543
Filed: 1997-10-10
Granted: 2000-08-17
Abstract: The invention includes methods of isolating DNA and a protein encoded thereby, the protein being capable of binding to an antigen-bearing moiety. The methods comprise generating a DNA library expressing the protein in a virus vector. A magnetic label is added to cells expressing the antigen-bearing moiety and the cells are incubated with virus expressing the protein in the presence of an excess of unlabeled cells which do not express the antigen-bearing moiety to form a mixture, wherein the virus binds to the magnetically labeled cells. Cells having virus bound thereon are isolated from the mixture and DNA encoding the protein and the protein are obtained therefrom.
Patent AU-712732-B2 (AU)
Title: Methods and compositions for in-vivo detection of oral cancers and precancerous conditions
Inventor: POMERANTZ EDWIN
IPC: A61P43/00
Filed: 1996-01-16
Granted: 1999-11-11
Abstract: PCT No. PCT/US96/00509 Sec. 371 Date Sep. 3, 1997 Sec. 102(e) Date Sep. 3, 1997 PCT Filed Jan. 16, 1996 PCT Pub. No. WO97/26018 PCT Pub. Date Jul. 24, 1997A method for in-vivo detection of premalignant oral lesions and oral carcinomas includes the step of applying to oral tissue a non-toxic dye other than toluidine blue O, selected from compounds having structure   <IMAGE>   and ionic derivatives thereof, wherein R1 is H, or lower alkyl group or N(R3)2, R2 is N, S or O, and R3 is H or a lower alkyl group.
Patent AU-720345-B2 (AU)
Title: Liquid ejecting head, liquid ejecting device and liquid ejecting method
Inventor: NAKATA YOSHIE
IPC: B41J2/16
Filed: 1996-04-26
Granted: 2000-05-25
Abstract: A tone gradation recording method, comprising:     providing a liquid ejection outlet; providing a first liquid flow path for first liquid in fluid communication with said liquid ejection outlet; providing a second liquid flow path for second liquid, adjacent to said first liquid flow path; providing a separation wall having a movable member between said first liquid flow path and said second liquid flow path; and ejecting, by displacement of said movable member toward said first liquid flow path, liquid which is a mixture of the first liquid and an amount of the second liquid on the basis of the amount of said first liquid, wherein the amount is controlled in accordance with the tone level to be recorded.   <IMAGE>
Patent AU-771432-B2 (AU)
Title: Interactive television program guide with remote access
Inventor: ELLIS MICHAEL D
IPC: H04H60/72
Filed: 1999-07-16
Granted: 2004-03-25
Abstract: An interactive television program guide with remote access is provided. The interactive television program guide is implemented on interactive television program guide equipment. A remote program guide access device is connected to the interactive television program guide equipment by a remote access link to provide a user with remote access to program guide functions.
Patent AU-582411-B2 (AU)
Title: Valve-provided connecting device
Inventor: WELLENSTAM KJELL INGEMAR
IPC: A61M5/00
Filed: 1985-12-24
Granted: 1989-03-23
Abstract: @ Valve-provided tube connecting device for connection with a liquid line intended to be connected to a patient, preferably for draining of body liquids. Said connecting device consists of a drip chamber house (1), a connecting house (2) containing a spring loaded valve body (7), which connecting house (2) is designed to connection with a connector (3). The valve body (7) consists of a conical upper sealing part (8), a guide part (11) and a solid, conical lower sealing part (12). The device attaining a closed system, which decreases the risk of bacteria infections and spillage.
Patent AU-726983-B2 (AU)
Title: Syringe with retractable needle assembly
Inventor: ADAMS ROBERT D
IPC: A61M5/32
Filed: 1997-11-14
Granted: 2000-11-30
Abstract: An improved syringe of the type having a hollow body which is closed at one end by an injection means and is open at the other end, the open end receives an elongated plunger means which moves through the hollow body and forces the contents of the body through the injection means. The improvement is comprised of an elastic member which retracts the injection means into a protective covering.
Patent AU-682160-B2 (AU)
Title: A method of producing visible, continuous streaks and/or delimited fields in paper
Inventor: SUNDBERG TORE
IPC: D21F1/44
Filed: 1993-11-09
Granted: 1997-09-25
Abstract: PCT No. PCT/SE93/00949 Sec. 371 Date Jun. 9, 1995 Sec. 102(e) Date Jun. 9, 1995 PCT Filed Nov. 9, 1993 PCT Pub. No. WO94/11577 PCT Pub. Date May 26, 1994The invention relates to a method of producing visible, preferably transparent or translucent, continuous streaks and/or delimited fields in paper in conjunction with forming a paper web in a paper machine. The method is characterized by essentially preventing dewatering of paper stock/paper fibres on one or more surfaces of a wire in the forming unit of a paper machine in conjunction with forming a paper web in the machine, and by applying a special stock that contains fibres which differ from the other fibre material deposited on the wire, optionally together with an arbitrary filler and/or binder. The invention also relates to a valuable document, such as a banknote, produced from the aforedescribed paper.
Patent AU-697683-B2 (AU)
Title: High voltage power supply having multiple high voltage generators
Inventor: KRICHTAFOVITCH IGOR A
IPC: H05G1/32
Filed: 1996-04-05
Granted: 1998-10-15
Abstract: A high voltage power supply (40) having a plurality of high voltage generators (50a, 50b, . . . 50j) that produce a controlled current in a load (24) having a capacitive component. Each high voltage generator consists of a pulsewidth-modulated (PWM) inverter, a high voltage transformer, and a high voltage full bridge rectifier. The high voltage generators are divided into three groups: Group I, Group II, and Group III. During a driving mode of power supply operation, the Group I, Group II, and Group III high voltage generators produce an output voltage (Vgen) from the power supply which exceeds a voltage (Vc) across the capacitive component of the load, causing the current in the load to increase. When the current in the load reaches a desired value, the power supply enters a tracking mode of operation. During the tracking mode, the Group I and Group II high voltage generators produce an output voltage (Vgen) from the power supply which equals the voltage (Vc) across the capacitive component of the load. The current through the load remains constant while the power supply tracks the voltage across the capacitive component of the load. The driving mode and the tracking mode are repeatedly performed, as the high voltage generators are driven by a square wave voltage (Vsw) produced by a timing generator (66). A control circuit (56) is also provided in the power supply to enable or disable additional Group II high voltage generators in response to fluctuations in the voltage across the load.
Patent AU-595515-B2 (AU)
Title: Aqueous chlorite matrix solution
Inventor: KUEHNE FRIEDRICH W
IPC: A61P31/00
Filed: 1986-04-30
Granted: 1990-04-05
Abstract: An aqueous solution of a chemically stabilized chlorite matrix for intravenous and perioperative administration in a dosed amount of 6.2x10-6 mole of ClO2- to 9.3x10-5 mole of ClO2- per kg of body weight to humans and animals is described.
Patent AU-643219-B2 (AU)
Title: Intermittent release dosage form
Inventor: KWAN LILIAN
IPC: A61K9/22
Filed: 1990-06-26
Granted: 1993-11-11
Abstract: Veterinary delayed release dosage forms which remain in the rumeno-reticular sac of an animal over an extended period of time and in which the therapeutically active substance has a predictable and delayed release pattern. The compositions comprise a dense filler, a disintegrant and a therapeutically active substance. The dosage form has a hydrophobic polymer or co-polymer coating and can deliver a plurality of doses of a medicament intermittently at a preset time interval in the rumen.
Patent AU-529319-B2 (AU)
Title: Disposal system
Inventor: COFFEY MANUS
IPC: B30B9/30
Filed: 1980-05-13
Granted: 1983-06-02
Abstract: The Specification concerns a refuse disposal system in which a refuse compacting unit located adjacent a wall of a building has a refuse input accessible from inside the building and a refuse output accessible from outside the building for discharging compacted refuse into a removable container. In order to permit a high degree of freedom in the placement of the container the unit is mounted on wheels for mobility and is located in an aperture in the wall, the aperture being substantially wider than the unit. The unit is disposed between a pair of sliding doors mounted for movement parallel to the wall, the doors being coupled to opposite sides of the unit by upwarding directed rollers on the doors engaging inverted channels along opposite sides of the unit. This arrangement permits free movement of the unit in a horizontal plane within the dimensional limitations of the arrangement, while ensuring that substantially the full width of the aperture in the wall is occupied by the combination of the unit and doors.
Patent AU-672879-B2 (AU)
Title: Aqueous pharmaceutical compositions of arginine amide
Inventor: IKEJIRI YOSHIFUMI
IPC: A61K31/47
Filed: 1994-04-19
Granted: 1996-10-17
Abstract: An aqueous agent comprising at least one arginine amide selected from the group consisting of (2R,4R)-4-methyl-1-[N<2>-((RS)-3-methyl-1,2,3,4-tetrahydro-8-quinoline sulfonyl)-L-arginyl]- 2-piperidinecarboxylic acid, monohydrate thereof and pharmacologically acceptable salts thereof, and at least one compound selected from the group consisting of cyclodextrin and caffeine; a method for improving the solubility of arginine amide in water, comprising adding at least one compound selected from the group consisting of cyclodextrin and caffeine; and a method for stabilizing arginine amide in water, comprising adding caffeine. According to the present invention, the solubility of arginine amide in water can be enhanced to, for example, a concentration permitting inhibition of fibrin formation at the time of entoptic operation. In addition, the stability of arginine amide in water can be enhanced with less irritation of the eye.
Patent AU-696402-B2 (AU)
Title: Oral 1alpha-hydroxyprevitamin D
Inventor: KNUTSON JOYCE C
IPC: A61P19/08
Filed: 1996-07-22
Granted: 1998-09-10
Abstract: Method of increasing activated vitamin D blood level by administering orally a 1 alpha -hydroxyprevitamin D. This previtamin D form increases vitamin D blood level without significant risk of hypercalcemia associated with other oral dosing of vitamin D forms. The 1 alpha -hydroxyprevitamin is compounded into a pharmaceutical composition in combination with a pharmaceutically acceptable excipient.
Patent AU-719786-B2 (AU)
Title: Diagnostic test for equine arteritis virus mediated disease
Inventor: CHIRNSIDE EWAN DOUGLAS
IPC: C07K14/165
Filed: 1996-06-20
Granted: 2000-05-18
Abstract: PCT No. PCT/GB96/01505 Sec. 371 Date Feb. 19, 1998 Sec. 102(e) Date Feb. 19, 1998 PCT Filed Jun. 20, 1996 PCT Pub. No. WO97/00963 PCT Pub. Date Jan. 9, 1997This invention relates to recombinant DNA and polypeptides encoded thereby which have use in the provision of vaccines, diagnostic test kits and methods of diagnosis and treatment or prophylaxis for equine arteritis virus (EAV) and EAV mediated disease.
Patent AU-761717-B2 (AU)
Title: Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
Inventor: BUELOW ROLAND
IPC: A61K38/00
Filed: 1998-04-10
Granted: 2003-06-05
Abstract: Novel oligonucleotides comprising a sequence derived by a computer program are provided for inhibiting cytotoxic activity of lymphocytic cells, inhibiting production of inflammatory cytokines and inflammatory responses associated with those cytokines, inhibiting the activity of heme-containing enzymes and delaying the onset of an autoimmune disease. By combining the subject compositions with mixtures of cells comprising lymphocytic cells and cells which would otherwise activate the lymphocytic cells, lysis of the target cells can be substantially inhibited. The oligopeptides may be joined to a variety of other groups or compounds for varying the activity of the subject composition. The subject compositions may be administered by any convenient means to inhibit lymphocytic attack on tissue, particularly involved with xenogeneic or allogeneic transplants or to inhibit the production of inflammatory cytokines and inflammatory responses associated therewith. The subject compositions may also be used in the inhibition of the activity of heme-containing enzymes.